Background: Systemic metastasis of a glial tumor is a rare event. However, metastatic cases are anticipated to increase due to prolongation of survival as a result of the development of new treatment modalities. The possibility of metastasis should be considered in patients with a history of a glial tumor rather than a second primary tumor. Fine-needle aspiration cytology is one of the diagnostic procedures primarily applied for confirmation of metastasis in cases with a known primary focus. Therefore, comprehensive knowledge of diagnostic cytomorphologic findings is required in these cases. Case Report: We report a young woman with oligodendroglioma metastasizing to the cervical lymphatic chain 5 years after initial diagnosis. Fine-needle aspiration cytology revealed a highly cellular smear with dispersed single cells and loosely cohesive cell clusters showing rosette-like features on a clean background. The relatively monotonous tumor cells were small sized and had round nuclei with moderate anisonucleosis and scant cytoplasm without extensions. Diagnostic confirmation was made by excisional biopsy and demonstration of 1p19q codeletion on tissue section by fluorescence in situ hybridization. Conclusion: A brief review of the literature with an emphasis on the cytologic features of metastatic oligodendroglioma and differential diagnosis with respect to other metastatic small round cell tumors is provided.

Keywords:
Extraneural metastasis, Oligodendroglioma, Aspiration cytology, 1p/19q deletion
1.
Reifenberger G, Kros JM, Louis DN, Collins VP: Oligodendroglial tumours; in Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds): World Health Organization Classification of Tumours of the Central Nervous System. Lyon, International Agency for Research on Cancer Press, 2007, pp 53–67.
2.
Merrell R, Nabors LB, Perry A, Palmer CA: 1p/19q chromosome deletions in metastatic oligodendroglioma. J Neurooncol 2006;80:203–207.
3.
Engelhard HH, Stelea A, Mundt A: Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis. Surg Neurol 2003;60:443–456.
4.
Zustovich F, Della Puppa A, Scienza R, Anselmi P, Furlan C, Cartei G: Metastatic oligodendrogliomas: a review of the literature and case report. Acta Neurochir (Wien) 2008;150:699–703.
5.
Jellinger K: Metastatic oligodendrogliomas: a review of the literature and case report. Acta Neurochir (Wien) 2009;151:987.
6.
Krijnen JL, Fleischeur RE, van Berkel M, Westenend PJ: Metastatic oligodendroglioma: a case report and incidence in The Netherlands. Clin Neuropathol 2010;29:141–146.
7.
Noshita N, Mashiyama S, Fukawa O, Asano S, Watanabe M, Tominaga T: Extracranial metastasis of anaplastic oligodendroglioma with 1p19q loss of heterozygosity – case report. Neurol Med Chir (Tokyo) 2010;50:161–164.
8.
Volavsek M, Lamovec J, Popović M: Extraneural metastases of anaplastic oligodendroglial tumors. Pathol Res Pract 2009;205:502–507.
9.
Uzuka T, Kakita A, Inenaga C, Takahashi H, Tanaka R, Takahashi H: Frontal anaplastic oligodendroglioma showing multi-organ metastases after a long clinical course. Case report. Neurol Med Chir (Tokyo) 2007;47:174–177.
10.
Ordonez NG, Ayala AG, Leavens ME: Extracranial metastases of oligodendroglioma: report of a case and review of the literature. Neurosurgery 1981;8:391–396.
11.
Liwnicz BH, Rubinstein LJ: The pathways of extraneural spread in metastasizing gliomas: a report of three cases and critical review of the literature. Hum Pathol 1979;10:453–467.
12.
Giordana MT, Ghimenti C, Leonardo E, Baltari I, Iudicello M, Duo D: Molecular genetic study of a metastatic oligodendroglioma. J Neurooncol 2004;66:265–271.
13.
Pansera F, Pansera E: An explanation for rarity of extracranial metastases in brain tumors. Med Hypotheses 1992;39:88–89.
14.
Schweitzer T, Vince GH, Herbold C, Roosen K, Tonn JC: Extraneural metastases of primary brain tumors. J Neurooncol 2001;53:107–114.
15.
Subramanian A, Harris A, Piggott K, Shieff C, Bradford R: Metastasis to and from the central nervous system – the ‘relatively protected site’. Lancet Oncol 2002;3:498–507.
16.
Macdonald DR, O’Brien RA, Gilbert JJ, Cairncross JG: Metastatic anaplastic oligodendroglioma. Neurology 1989;39:1593–1596.
17.
Houston SC, Crocker IR, Brat DJ, Olson JJ: Extraneural metastatic glioblastoma after interstitial brachytherapy. Int J Radiat Oncol Biol Phys 2000;48:831–836.
18.
Garner J, Morcos Y, Bari M: Extradural cord compression due to metastatic oligodendroglioma. J Neurooncol 2002;58:71–75.
19.
Lee CC, Jiang JS, Chen ET, Yokoo H, Pan YH, Tsai MD: Cytologic diagnosis of a metastatic oligodendroglioma in a pleural effusion. A case report. Acta Cytol 2006;50:542–544.
20.
Han SR, Yoon SW, Yee GT, Choi CY, Lee DJ, Sohn MJ, Chang SH, Whang CJ: Extraneural metastases of anaplastic oligodendroglioma. J Clin Neurosci 2008;15:946–949.
21.
Lopez-Rios F, Alberti N, Ballestin C, Pérez-Barrios A, de Agustín P: Extracranial metastases of a glioma: diagnosis by fine needle aspiration and immunocytochemistry. Diagn Cytopathol 2000;23:43–45.
22.
Anand M, Kumar R, Jain P, Gupta R, Ghosal N, Sharma A, Agarwal A, Sharma MC: Metastatic anaplastic oligodendroglioma simulating acute leukemia. A case report. Acta Cytol 2003;47:467–469.
23.
Monabati A, Kumar PV, Roozbehi H, Torabinezhad S: Cytologic findings in metastatic oligodendroglioma. Acta Cytol 2003;47:702–704.
24.
Wang M, Murphy KM, Kulesza P, Hatanpaa KJ, Olivi A, Tufaro A, Erozan Y, Westra WH, Burger PC, Berg KD: Molecular diagnosis of metastasizing oligodendroglioma: a case report. J Mol Diagn 2004;6:52–57.
25.
Watson CW, Hajdu SI: Cytology of primary neoplasms of the central nervous system. Acta Cytol 1977;21:40–47.
26.
Mitsuhashi T, Shimizu Y, Ban S, Ogawa F, Matsutani M, Shimizu M, Hirose T: Anaplastic oligodendroglioma: a case report with characteristic cytologic features, including minigemistocytes. Acta Cytol 2007;51:657–660.
27.
Kojima H, Mori K, Fukudome N, Iseki M, Shimizu S: Cytologic characteristics of intracytoplasmic refractile eosinophilic granular bodies in anaplastic oligodendroglioma: a case report. Acta Cytol 2008;52:467–470.
28.
Schultz S, Pinsky GS, Wu NC, Chamberlain MC, Rodrigo AS, Martin SE: Fine needle aspiration diagnosis of extracranial glioblastoma multiforme: case report and review of the literature. Cytojournal 2005;2:19.
29.
Dawson TP: Pancytopaenia from a disseminated anaplastic oligodendroglioma. Neuropathol Appl Neurobiol 1997;23:516–520.
30.
Choon A, Roepke JE: Importance of immunohistochemical staining in metastatic anaplastic oligodendroglioma. Arch Pathol Lab Med 2004;128:489–490.
31.
Ligon KL, Alberta JA, Kho AT, Weiss J, Kwaan MR, Nutt CL, Louis DN, Stiles CD, Rowitch DH: The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol 2004;63:499–509.
32.
Scheie D, Andresen PA, Cvancarova M, Bø AS, Helseth E, Skullerud K, Beiske K: Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors. Am J Surg Pathol 2006;30:828–837.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.